Neuroprotection by ketamine: a review of the experimental and clinical evidence

J Cardiothorac Vasc Anesth. 2010 Feb;24(1):131-42. doi: 10.1053/j.jvca.2009.05.008. Epub 2009 Jul 29.

Authors

Judith A Hudetz¹, Paul S Pagel

Affiliation

¹ Department of Anesthesiology, Medical College of Wisconsin and Clement J. Zablocki Veterans Administration Medical Center, 5000 W National Avenue, Milwaukee, WI 53295, USA. judith.hudetz@va.gov

PMID: 19640746
DOI: 10.1053/j.jvca.2009.05.008

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Brain Ischemia / prevention & control*
Cardiopulmonary Bypass / adverse effects*
Cerebrovascular Circulation / drug effects
Excitatory Amino Acid Antagonists / therapeutic use*
Humans
Hypoxia / etiology
Hypoxia / physiopathology
Ketamine / therapeutic use*
Neuroprotective Agents / therapeutic use*
Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
Reperfusion Injury / prevention & control*
Surgical Procedures, Operative

Substances

Excitatory Amino Acid Antagonists
Neuroprotective Agents
Receptors, N-Methyl-D-Aspartate
Ketamine